What is Maze Therapeutics, Inc. Common Stock's Market Cap?

Maze Therapeutics, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's Enterprise Value?

Maze Therapeutics, Inc. Common Stock's Enterprise Value is $993.3M, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's EV / EBITDA?

Maze Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's Net Income (TTM)?

Maze Therapeutics, Inc. Common Stock's Net Income (TTM) is -$133.6M, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's EBITDA?

Maze Therapeutics, Inc. Common Stock's EBITDA is -$143.7M, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Maze Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.40, based on as-reported figures from SEC (XBRL) filings.

What is Maze Therapeutics, Inc. Common Stock's Net Debt?

Maze Therapeutics, Inc. Common Stock's Net Debt is -$372.1M, based on as-reported figures from SEC (XBRL) filings.

Maze Therapeutics, Inc. Common Stock (MAZE) Financial Statements

Maze Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00NHJHS36

XNAS · usd

24.58▼ 1.79 (-6.79%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close26.37

Day's Range24.39 – 26.55

52-Week Range14.75 – 53.68

Volume401.4K

Avg Volume369.4K

Share Statistics

Shares Outstanding

Employees141

ExchangeXNAS

Listed2025-01-31

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Maze Therapeutics, Inc. Common Stock (MAZE)

What is Maze Therapeutics, Inc. Common Stock's Market Cap?: Maze Therapeutics, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's Enterprise Value?: Maze Therapeutics, Inc. Common Stock's Enterprise Value is $993.3M, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's EV / EBITDA?: Maze Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's Net Income (TTM)?: Maze Therapeutics, Inc. Common Stock's Net Income (TTM) is -$133.6M, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's EBITDA?: Maze Therapeutics, Inc. Common Stock's EBITDA is -$143.7M, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Maze Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.40, based on as-reported figures from SEC (XBRL) filings.
What is Maze Therapeutics, Inc. Common Stock's Net Debt?: Maze Therapeutics, Inc. Common Stock's Net Debt is -$372.1M, based on as-reported figures from SEC (XBRL) filings.